The Management of Obesity in 2023: An Update
Stephen Glazer2023Canadian Primary Care TodayJournal Article
CardiovascularEndocrine (ADH/ACTH/MSH)
Abstract
In 2015, obesity was declared by the Canadian Medical Association (CMA) and other global health organizations (World Health Organization [WHO], World Obesity Federation and the American Medical Association [AMA]) to be a chronic, relapsing and remitting disease caused by the deposition of adipose tissue in organ systems within the body leading to dysfunction and adverse health outcomes. Obesity should be medically addressed no differently than other chronic illnesses such as diabetes, hypertension or coronary artery disease.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 2 shared tags
- Childhood Obesity: Insight into Kidney InvolvementInternational Journal of Molecular Sciences · 2023 · 2 shared tags
- The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes—New PerspectivesAntioxidants · 2023 · 2 shared tags
- Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2026 · 2 shared tags
- Extracellular vesicle-associated miR-515-5p from adipose tissue regulates placental metabolism and fetal growth in gestational diabetes mellitusCardiovascular Diabetology · 2025 · 2 shared tags
- The Interplay Between Obesity and Venous Thromboembolism: From Molecular Aspects to Clinical IssueInternational Journal of Molecular Sciences · 2025 · 2 shared tags